IFx-Hu2.0 Expanded Access Program

TuHURA Biosciences

Status

Conditions: Cutaneous Melanoma, Stage III; Cutaneous Squamous Cell Carcinoma; Cutaneous Melanoma, Stage IV; Merkel Cell Carcinoma

Treatments: Biological: IFx-Hu2.0

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT04853602

IFx-Hu2.0 Expanded Access

Details and patient eligibility

About

Expanded access requests for IFx-Hu2.0 may be considered for the treatment of adult patients (greater than or equal to 18 years of age) with stage III through IV cutaneous melanoma, advanced Merkel cell carcinoma (MCC), or advanced cutaneous squamous cell carcinoma (cSCC) who have failed all available treatment options.

To request access, use Responsible Party contact information provided in this record..

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• To request more information use Responsible Party contact information provided in this record

Exclusion criteria

• To request more information use Responsible Party contact information provided in this record